Clinical Study to Evaluate Effect on Fatty Liver and Safety of Trehalose
Status:
Completed
Trial end date:
2018-03-20
Target enrollment:
Participant gender:
Summary
This clinical study is conducted to evaluate the effect on fatty liver and safety of
Trehalose, which is also called as mycose or tremalose, for participants with non-alcoholic
fatty liver. After 12 weeks multiple-dose, participants will be checked up by CT scan to
evaluate the effects.